DAVID THOMSON, PH.D., J.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

MANNKIND CORP

Filing Date Source Excerpt
2017-11-17 David Thomson, Ph.D., J.D.(5) 389,535 * Includes 4,622 shares which Dr. Thomson has the right to acquire within 60 days of October 30, 2017 pursuant to the exercise of outstanding options.

Data sourced from SEC filings. Last updated: 2025-10-12